CO5580737A2 - Composiciones y metodos para administrar unguentos antibacterianos, antimicoticos y antivirales a las cavidades bucal, nasal o vaginal - Google Patents

Composiciones y metodos para administrar unguentos antibacterianos, antimicoticos y antivirales a las cavidades bucal, nasal o vaginal

Info

Publication number
CO5580737A2
CO5580737A2 CO04044710A CO04044710A CO5580737A2 CO 5580737 A2 CO5580737 A2 CO 5580737A2 CO 04044710 A CO04044710 A CO 04044710A CO 04044710 A CO04044710 A CO 04044710A CO 5580737 A2 CO5580737 A2 CO 5580737A2
Authority
CO
Colombia
Prior art keywords
water
further characterized
ointment
soluble
components
Prior art date
Application number
CO04044710A
Other languages
English (en)
Inventor
Ahmad Nawaz
Shun Y Lin
Kalpana J Patel
Mark Huseth
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Publication of CO5580737A2 publication Critical patent/CO5580737A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56961—Plant cells or fungi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Food Science & Technology (AREA)
  • Botany (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

1.- Un ungüento antimicótico que comprende: uno o más agentes antimicóticos; uno o más componentes insolubles en agua; y uno o más componentes hidrosolubles.2.- El ungüento de conformidad con la reivindicación 1, caracterizado además porque los componentes insolubles en agua comprenden uno o más del grupo que consiste de petrolato y base de aceite vegetal.3.- El ungüento de conformidad con la reivindicación 1, caracterizado además porque los componentes insolubles en agua comprenden alcohol estearílico.4.- El ungüento de conformidad con la reivindicación 1, caracterizado además porque los componentes insolubles en agua tienen una mezcla de temperaturas de fusión alta y baja.5.- El ungüento de conformidad con la reivindicación 1, caracterizado además porque los componentes hidrosolubles comprenden uno o más componentes que se seleccionan del grupo que consiste de polietilenglicoles, propilenglicoles y glicerina.6.- El ungüento de conformidad con la reivindicación 1, caracterizado además porque los componentes hidrosolubles comprenden uno o más polietilenglicoles.7.- El ungüento de conformidad con la reivindicación 1, caracterizado además porque los componentes hidrosolubles e insolubles en agua están presentes en una proporción, de aproximadamente 2:3 a aproximadamente 3:48.- El ungüento de conformidad con la reivindicación 1, caracterizado además porque los componentes hidrosoluble e insoluble en agua están presentes en una proporción, en donde la proporción provoca que el agente antimicótico esté presente por lo menos parcialmente en elcomponente hidrosoluble.9.- EI ungüento de conformidad con la reivindicación 1, caracterizado además porque también comprende uno o más tensioactivos no iónicos.10.- El ungüento de conformidad con la reivindicación 9 caracterizado además porque el tensioactivo comprende Polysorbate 60.
CO04044710A 2001-10-16 2004-05-14 Composiciones y metodos para administrar unguentos antibacterianos, antimicoticos y antivirales a las cavidades bucal, nasal o vaginal CO5580737A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/978,810 US20030091540A1 (en) 2001-10-16 2001-10-16 Compositions and methods for delivering antibacterial, antifungal and antiviral ointments to the oral, nasal or vaginal cavity

Publications (1)

Publication Number Publication Date
CO5580737A2 true CO5580737A2 (es) 2005-11-30

Family

ID=25526408

Family Applications (1)

Application Number Title Priority Date Filing Date
CO04044710A CO5580737A2 (es) 2001-10-16 2004-05-14 Composiciones y metodos para administrar unguentos antibacterianos, antimicoticos y antivirales a las cavidades bucal, nasal o vaginal

Country Status (12)

Country Link
US (1) US20030091540A1 (es)
EP (1) EP1435907A2 (es)
JP (1) JP2005511530A (es)
KR (1) KR20040063909A (es)
CN (1) CN1630509A (es)
AU (1) AU2002335001A1 (es)
BR (1) BRPI0213383A2 (es)
CA (1) CA2463711A1 (es)
CO (1) CO5580737A2 (es)
MX (1) MXPA04003656A (es)
RU (1) RU2004111594A (es)
WO (1) WO2003032948A2 (es)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060122095A1 (en) * 2002-09-12 2006-06-08 Brid Delvin Mucus formulation for mucosal surfaces and uses thereof
BR0317555A (pt) * 2002-12-18 2005-11-22 Ferrer Int Composições farmacêuticas de sertaconazol para uso vaginal
JP2004345999A (ja) * 2003-05-21 2004-12-09 Taiko Pharmaceutical Co Ltd 菌体製剤組成物
US8211906B1 (en) * 2003-08-05 2012-07-03 Scherrer Lawrence C Method of inhibiting growth of neoplastic cells and inhibiting infection by administering an immune enhancer drug
US20050058673A1 (en) 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
AU2004274000B2 (en) 2003-09-19 2009-07-30 Drugtech Corporation Pharmaceutical delivery system
US20060140990A1 (en) * 2003-09-19 2006-06-29 Drugtech Corporation Composition for topical treatment of mixed vaginal infections
US20050222169A1 (en) * 2004-01-16 2005-10-06 Nawaz Ahmad Compositions and methods of treating infections
CA2557834C (en) * 2004-03-04 2012-05-22 E-L Management Corporation Skin treatment method with lactobacillus extract
US20070065504A1 (en) * 2004-03-23 2007-03-22 Lin Shun Y Products and methods for treating vaginal infections
US20050214364A1 (en) * 2004-03-23 2005-09-29 Hutman Herbert W Products and methods for treating vaginal infections
US9028852B2 (en) 2004-09-07 2015-05-12 3M Innovative Properties Company Cationic antiseptic compositions and methods of use
US20060078580A1 (en) * 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US7740875B2 (en) * 2004-10-08 2010-06-22 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
EP1698336A1 (en) * 2005-03-01 2006-09-06 Ferrer Internacional, S.A. Antifungal compositions comprising Sertaconazole and either Hydrocortisone or an antibacterial agent
BRPI0608690B8 (pt) 2005-03-10 2021-05-25 3M Innovative Properties Co uso de uma composição antimicrobiana
AU2006223136A1 (en) 2005-03-10 2006-09-21 3M Innovative Properties Company Antimicrobial compositions comprising esters of hydroxycarboxylic acids
JP2008540534A (ja) * 2005-05-09 2008-11-20 ドラッグテック コーポレイション 放出調節薬学組成物
KR100720025B1 (ko) * 2005-09-27 2007-05-21 (주)바이오토피아 프로바이오틱 유산균 및 이를 포함하는 조성물
US8258191B2 (en) * 2005-10-31 2012-09-04 Coloplast A/S Topical skin barriers and methods of evaluation thereof
US8211871B2 (en) * 2005-10-31 2012-07-03 Coloplast A/S Topical skin barriers and methods of evaluation thereof
US20070224226A1 (en) * 2006-01-05 2007-09-27 Drugtech Corporation Composition and method of use thereof
KR100720024B1 (ko) * 2006-12-20 2007-05-18 (주)바이오토피아 프로바이오틱 비피도박테리움 보움 ｒ5 균주 및 이를포함하는 조성물
WO2009010986A1 (en) * 2007-07-19 2009-01-22 Glenmark Pharmaceuticals Limited Topical cream compositions of sertaconazole nitrate
CN101951779A (zh) 2007-12-31 2011-01-19 3M创新有限公司 抗微生物组合物
US20110200569A1 (en) * 2008-05-22 2011-08-18 University College Cork-National University Of Ireland Cork Increasing the shelf life of bakery and patisserie products by using the antifungal lactobacillus amylovorus dsm 19280
WO2010047831A1 (en) * 2008-10-23 2010-04-29 Nycomed Us Inc. Stable metronidazole gel formulations
IT1393777B1 (it) * 2009-04-03 2012-05-08 Rottapharm Spa Composizione per l'igiene intima
US8747814B2 (en) * 2009-08-17 2014-06-10 The Procter & Gamble Company Oral care compositions and methods
AU2010328269B2 (en) * 2009-12-08 2014-07-10 Smith & Nephew Orthopaedics Ag Enzymatic wound debriding compositions with enhanced enzymatic activity
ES2652338T3 (es) 2010-11-05 2018-02-01 The Procter & Gamble Company Aplicador para el cuidado bucal
BG66608B1 (bg) * 2011-05-04 2017-10-16 "Ел Би Булгарикум" ЕАД Полибактериален пробиотичен препарат
MX2017000814A (es) 2014-07-31 2017-05-04 Kimberly Clark Co Composicion antiadherente a base de alcohol.
GB2544218B (en) * 2014-07-31 2021-06-23 Kimberly Clark Co Anti-adherent composition
WO2016018474A1 (en) 2014-07-31 2016-02-04 Kimberly-Clark Worldwide, Inc. Anti-adherent composition
AU2015311674B2 (en) 2014-09-05 2018-03-08 Evofem Biosciences, Inc. Secnidazole for use in the treatment of bacterial vaginosis
CZ201523A3 (cs) * 2015-01-16 2016-07-27 Bio Agens Research And Development - Bard, S.R.O. Duální mikrobiální preparát pro dlouhodobé potlačení nebo prevenci symptomů oportunních mikrobiálních infekcí
US11737458B2 (en) 2015-04-01 2023-08-29 Kimberly-Clark Worldwide, Inc. Fibrous substrate for capture of gram negative bacteria
US11253501B2 (en) 2015-06-01 2022-02-22 Lupin Inc. Secnidazole formulations and use in treating bacterial vaginosis
CN105309809A (zh) * 2015-11-30 2016-02-10 大理双胞胎饲料有限公司 一种新型猪用绿色饲料添加剂
US12037497B2 (en) 2016-01-28 2024-07-16 Kimberly-Clark Worldwide, Inc. Anti-adherent composition against DNA viruses and method of inhibiting the adherence of DNA viruses to a surface
AU2016408394B2 (en) 2016-05-26 2021-11-11 Kimberly-Clark Worldwide, Inc. Anti-adherent compositions and methods of inhibiting the adherence of microbes to a surface
CN107551274A (zh) * 2017-09-29 2018-01-09 佛山市南海东方澳龙制药有限公司 一种动物抗真菌制剂及其制备方法
CN112501051B (zh) * 2020-11-05 2023-01-10 内蒙古普泽生物制品有限责任公司 一种益生菌复合制剂及其在阴道菌群调节以及抗hpv中的应用
WO2023162363A1 (ja) * 2022-02-28 2023-08-31 株式会社大塚製薬工場 水中油型乳化組成物
JP7289174B1 (ja) * 2022-02-28 2023-06-09 株式会社大塚製薬工場 水中油型乳化組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3888995A (en) * 1968-07-19 1975-06-10 Syntex Corp Fatty alcohol-propylene glycol vehicle
CA1274508A (en) * 1984-05-31 1990-09-25 Imre Szilagyi Primycin components and process for the separation of the antibiotic complex
US4636520A (en) * 1984-07-16 1987-01-13 Fujisawa Pharmaceutical Co., Ltd. Antifungal composition employing pyrrolnitrin in combination with an imidazole compound
US4895727A (en) * 1985-05-03 1990-01-23 Chemex Pharmaceuticals, Inc. Pharmaceutical vehicles for exhancing penetration and retention in the skin
US5422361A (en) * 1989-12-20 1995-06-06 Schering Corporation Stable cream and lotion bases for lipophilic drug compositions
US5174475A (en) * 1991-03-26 1992-12-29 Glaxo Inc. Sequential dosing of antifungal and antiinflammatory compositions
US5733568A (en) * 1993-12-03 1998-03-31 Lafor Laboratories Limited Micro-encapsulated lactobacilli for medical applications
US5514698A (en) * 1994-03-21 1996-05-07 Ortho Pharmaceutical Corporation Antifungal vaginal cream composition
IT1284874B1 (it) * 1996-08-02 1998-05-22 Farmigea Spa Complessi bioadesivi di polycarbophil e farmaci antifungini o antiprotozoari azolici

Also Published As

Publication number Publication date
EP1435907A2 (en) 2004-07-14
WO2003032948A2 (en) 2003-04-24
US20030091540A1 (en) 2003-05-15
BRPI0213383A2 (pt) 2016-06-21
CA2463711A1 (en) 2003-04-24
KR20040063909A (ko) 2004-07-14
RU2004111594A (ru) 2005-03-20
AU2002335001A1 (en) 2003-04-28
JP2005511530A (ja) 2005-04-28
MXPA04003656A (es) 2005-06-20
CN1630509A (zh) 2005-06-22
WO2003032948A3 (en) 2003-11-13

Similar Documents

Publication Publication Date Title
CO5580737A2 (es) Composiciones y metodos para administrar unguentos antibacterianos, antimicoticos y antivirales a las cavidades bucal, nasal o vaginal
ES2683330T3 (es) Desinfectante de la piel basado en peróxido de hidrógeno
CO5200793A1 (es) Microemulsion antimicrobiana para propositos multiples que contiene un agente tensoactivo cationico
AR035803A1 (es) Composiciones antibacterianas de gran eficacia con mejoras en las propiedades esteticas y de cuidado de la piel y metodo para reducir una poblacion bacteriana
AR052252A1 (es) Formulaciones topicas de nepafenac
ES2741780T3 (es) Composiciones antimicrobianas
AU2016329888B2 (en) Alcohol-based skin sanitizer having microbicidal properties
CR8722A (es) Composiciones de metadona para uso topico y metodos para el uso de las mismas
AR059113A1 (es) Composicion para administracion topica
AR040205A1 (es) Composicion herbicida
BR0113751A (pt) Composições cosméticas e farmacêuticas e seus empregos
AR066905A1 (es) Administracion intranasal de asenapina y composiciones farmaceuticas correspondientes
CO6300928A2 (es) Un agente de espumado que comprende un tensoactivo no ionico, un tensoactivo zwiterionico y que esta libre de tensoactivos anionicos
BR0209317A (pt) Composições incluindo tensoativos com base em vitamina e métodos para usar as mesmas
HN1999000135A (es) Formulacion liquida.
AR057648A1 (es) Composicion de metaflumizona para la administracion topica
AR052882A1 (es) Composicion antihelmintica
AR037047A1 (es) Baja concentracion de peroxido para el tratamiento o prevencion de enfermedades vaginales
AR100001A1 (es) Composiciones esporicidas clostridium difficile
AR006345A1 (es) Una composicion farmaceutica para administracion oral que comprende un inhibidor de proteasa del vih y un derivado de tocoferol soluble en agua, y un metodo para preparar dicha composicion.
SI21079B (sl) Formulacija, ki povecuje mobilizacijo
CR10835A (es) Formulaciones de aminoacidos mejoradas
ES2259274B2 (es) Crema reparadora para piel dañada.
AR038012A1 (es) Detergente liquido en capas para el lavado de la ropa con una capa inferior de color
ATE483447T1 (de) Auf licht reagierende duftstoffe

Legal Events

Date Code Title Description
FC Application refused